Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Free Cash Flow: 2019-2024

Historic Free Cash Flow for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to -$251.1 million.

  • Relay Therapeutics' Free Cash Flow rose 17.52% to -$62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$248.9 million, marking a year-over-year increase of 11.93%. This contributed to the annual value of -$251.1 million for FY2024, which is 17.51% up from last year.
  • Relay Therapeutics' Free Cash Flow amounted to -$251.1 million in FY2024, which was up 17.51% from -$304.4 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Free Cash Flow registered a high of -$77.9 million during FY2021, and its lowest value of -$304.4 million during FY2023.
  • Moreover, its 3-year median value for Free Cash Flow was -$251.1 million (2024), whereas its average is -$264.7 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first climbed by 25.42% in 2021, then slumped by 206.32% in 2022.
  • Relay Therapeutics' Free Cash Flow (Yearly) stood at -$104.4 million in 2020, then grew by 25.42% to -$77.9 million in 2021, then plummeted by 206.32% to -$238.6 million in 2022, then declined by 27.62% to -$304.4 million in 2023, then grew by 17.51% to -$251.1 million in 2024.